Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
May 03 2019 - 4:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES
EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-35993
OncoMed Pharmaceuticals, Inc.
(Exact name of registrant as specified in
its charter)
800 Chesapeake Drive
Redwood City, California 94063
(650) 995-8200
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Common Stock, $0.001 par value per share
(Title of each class of securities covered
by this Form)
None
(Titles of all other classes of securities
for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate
rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
|
|
☒
|
Rule 12g-4(a)(2)
|
|
☐
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
Rule 15d-6
|
|
☐
|
Rule 15d-22(b)
|
|
☐
|
Approximate number of holders of record as of the certification
or notice date: One
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, OncoMed Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly
authorized person.
Date: May 3, 2019
|
|
|
|
By:
|
|
/s/ Denise Scots-Knight
|
|
|
|
|
Denise Scots-Knight
President
|
|
ONCOMED PHARMACEUTICALS INC (NASDAQ:OMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
ONCOMED PHARMACEUTICALS INC (NASDAQ:OMED)
Historical Stock Chart
From Apr 2023 to Apr 2024